Lamivudine Plus Low-Dose Hepatitis B Immunoglobulin to Prevent Recurrent Hepatitis B Following Liver Transplantation
Open Access
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 132 (3) , 931-937
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Living donor liver transplantation for hepatitis B cirrhosisLiver Transplantation, 2003
- Immunization With An Adjuvant Hepatitis B Vaccine After Liver Transplantation for Hepatitis B–Related DiseaseHepatology, 2003
- Hbv Dna Persistence 10 Years After Liver Transplantation Despite Successful Anti–Hbs Passive ImmunoprophylaxisHepatology, 2003
- Preliminary results: Outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotypeLiver Transplantation, 2002
- PREOPERATIVE ANTIVIRAL TREATMENT AND POSTOPERATIVE PROPHYLAXIS IN HBV-DNA POSITIVE PATIENTS UNDERGOING LIVER TRANSPLANTATIONTransplantation, 2001
- Factors associated with hepatitis B virus DNA breakthrough in patients receiving prolonged lamivudine therapyHepatology, 2001
- Early Detection of Viral Resistance by Determination of Hepatitis B Virus Polymerase Mutations in Patients Treated by Lamivudine for Chronic Hepatitis BHepatology, 2000
- Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipientGut, 2000
- Lamivudine therapy in patients undergoing liver transplantation for hepatitis b virus precore mutant-associated infection: High resistance rates in treatment of recurrence but universal prevention if used as prophylaxis with very low dose hepatitis B immuLiver Transplantation and Surgery, 1999
- Hepatitis B virus reinfection after orthotopic liver transplantationJournal of Hepatology, 1992